Something like this could only be answered via an ASX announcement given its price sensitivity.
Everyone should keep in mind that we only get one chance to impress large pharma and that the large pharma business development teams are very risk adverse. The way large pharma is structured the BD teams would rather pay $10 billion for an asset with a 50% of success than $100m for an asset with a 25% chance of success.
General Comments / Chat, page-11270
-
- There are more pages in this discussion • 630 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.77%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.53 | $83.43K | 53.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20575 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |